The Guardian

Scientists, politicians and activists expect the first commercially cultivated GM crops to be planted in England in 2017 after an EU vote for new GM crop rules last week, but the battle for biotechnology is far from done.

GM serves as a proxy and arena for a dizzying range of debates in the EU splitting industry and environmentalists. These cover trade deals, agricultural herbicide use, subsidiarity (dealing with social issues at a local level), evidence-based science and the precautionary principle.

With an average GM crop costing between $200m-$300m to bring to market, and potential returns that run into billions, lobbyists on all sides are sharpening their pencils in the corridors of Brussels.

Get Our E-Newsletter - breaking news to your in-box twice a week
Will be used in accordance with our Privacy Policy

About The Author